|
|
response to muramyl dipeptide
|
GO:0032495 |
4 |
0.876
|
|
|
|
positive regulation of type i interferon production
|
GO:0032481 |
20 |
0.835
|
|
|
|
interferon beta production
|
GO:0032608 |
23 |
0.834
|
|
|
|
regulation of interferon alpha production
|
GO:0032647 |
11 |
0.823
|
|
|
|
response to peptidoglycan
|
GO:0032494 |
3 |
0.764
|
|
|
|
response to interferon beta
|
GO:0035456 |
11 |
0.759
|
Human |
|
|
interferon alpha production
|
GO:0032607 |
11 |
0.758
|
|
|
|
type i interferon biosynthetic process
|
GO:0045351 |
4 |
0.742
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.721
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.704
|
Human |
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.671
|
Human |
|
|
response to peptide
|
GO:1901652 |
65 |
0.649
|
Human |
|
|
adaptive immune response
|
GO:0002250 |
49 |
0.581
|
|
|
|
regulation of interferon beta production
|
GO:0032648 |
22 |
0.578
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.577
|
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
11 |
0.552
|
|
|
|
regulation of regulatory t cell differentiation
|
GO:0045589 |
4 |
0.531
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.519
|
Human |
|
|
type i interferon signaling pathway
|
GO:0060337 |
11 |
0.469
|
|
|
|
cytokine metabolic process
|
GO:0042107 |
38 |
0.441
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.421
|
Human |
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.414
|
Human |
|
|
type i interferon production
|
GO:0032606 |
27 |
0.412
|
|
|
|
positive regulation of interferon beta production
|
GO:0032728 |
17 |
0.401
|
|
|
|
cytokine biosynthetic process
|
GO:0042089 |
37 |
0.380
|
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
24 |
0.379
|
Human |
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.372
|
Human |
|
|
response to mechanical stimulus
|
GO:0009612 |
51 |
0.342
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.340
|
Human |
|
|
regulation of adaptive immune response
|
GO:0002819 |
33 |
0.328
|
|
|
|
cellular response to mechanical stimulus
|
GO:0071260 |
39 |
0.294
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.265
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.264
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.252
|
|
|
|
negative regulation of viral process
|
GO:0048525 |
66 |
0.245
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.240
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.233
|
Human |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.218
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.214
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
109 |
0.208
|
|
|
|
cellular response to interleukin 12
|
GO:0071349 |
3 |
0.205
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.197
|
|
|
|
defense response to virus
|
GO:0051607 |
71 |
0.194
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
97 |
0.184
|
|
|
|
positive regulation of interleukin 4 biosynthetic process
|
GO:0045404 |
1 |
0.183
|
|
|
|
regulation of type i interferon production
|
GO:0032479 |
26 |
0.183
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.181
|
Human |
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.178
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.177
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.176
|
|
|
|
neuron projection regeneration
|
GO:0031102 |
1 |
0.166
|
|
|
|
jak stat cascade involved in growth hormone signaling pathway
|
GO:0060397 |
2 |
0.164
|
Human |
|
|
immune response
|
GO:0006955 |
307 |
0.158
|
Human |
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.148
|
|
|
|
protein import into nucleus
|
GO:0006606 |
104 |
0.148
|
Human |
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.146
|
|
|
|
interleukin 6 mediated signaling pathway
|
GO:0070102 |
7 |
0.146
|
Human |
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.145
|
Human |
|
|
cytokine production
|
GO:0001816 |
247 |
0.140
|
|
|
|
cell migration involved in gastrulation
|
GO:0042074 |
1 |
0.137
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.135
|
Human |
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
109 |
0.134
|
Human |
|
|
interleukin 2 mediated signaling pathway
|
GO:0038110 |
3 |
0.134
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.128
|
Human |
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.127
|
Human |
|
|
response to interferon gamma
|
GO:0034341 |
39 |
0.125
|
Human |
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.120
|
Human |
|
|
immune effector process
|
GO:0002252 |
159 |
0.116
|
|
|
|
activation of immune response
|
GO:0002253 |
114 |
0.115
|
|
|
|
actin mediated cell contraction
|
GO:0070252 |
12 |
0.111
|
|
|
|
cellular response to interleukin 4
|
GO:0071353 |
7 |
0.108
|
Human |
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.108
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.106
|
|
|
|
cellular response to type i interferon
|
GO:0071357 |
12 |
0.102
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.100
|
Human |
|
|
positive regulation of interleukin 13 production
|
GO:0032736 |
4 |
0.098
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
156 |
0.097
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.096
|
Human |
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.096
|
|
|
|
actin filament based movement
|
GO:0030048 |
17 |
0.096
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.095
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
262 |
0.095
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
43 |
0.094
|
Human |
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.091
|
|
|
|
nuclear import
|
GO:0051170 |
106 |
0.085
|
Human |
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.084
|
|
|
|
interleukin 4 mediated signaling pathway
|
GO:0035771 |
3 |
0.083
|
Human |
|
|
compound eye development
|
GO:0048749 |
1 |
0.082
|
|
|
|
ciliary neurotrophic factor mediated signaling pathway
|
GO:0070120 |
5 |
0.082
|
|
|
|
cellular response to interleukin 6
|
GO:0071354 |
14 |
0.081
|
Human |
|
|
histone modification
|
GO:0016570 |
251 |
0.080
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
64 |
0.080
|
|
|
|
regulation of interleukin 12 production
|
GO:0032655 |
15 |
0.080
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.080
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.079
|
|
|
|
multi organism cellular process
|
GO:0044764 |
156 |
0.078
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
81 |
0.078
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.077
|
|
|
|
negative regulation of type 2 immune response
|
GO:0002829 |
3 |
0.077
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.076
|
|
|
|
positive regulation of interleukin 12 production
|
GO:0032735 |
8 |
0.075
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.075
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.075
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
156 |
0.074
|
|
|
|
regulation of immune response
|
GO:0050776 |
201 |
0.073
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
65 |
0.072
|
Human |
|
|
axon regeneration
|
GO:0031103 |
1 |
0.072
|
|
|
|
cd8 positive alpha beta t cell differentiation
|
GO:0043374 |
1 |
0.072
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.071
|
|
|
|
protein targeting to nucleus
|
GO:0044744 |
104 |
0.071
|
Human |
|
|
macromolecule glycosylation
|
GO:0043413 |
63 |
0.070
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.070
|
|
|
|
positive regulation of interleukin 4 production
|
GO:0032753 |
3 |
0.067
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
25 |
0.066
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
122 |
0.066
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.064
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.063
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.063
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.062
|
Human |
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
82 |
0.061
|
|
|
|
glycosylation
|
GO:0070085 |
71 |
0.061
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.059
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.059
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.058
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.058
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.057
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.057
|
|
|
|
memory
|
GO:0007613 |
3 |
0.055
|
|
|
|
convergent extension
|
GO:0060026 |
1 |
0.055
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
74 |
0.055
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.053
|
|
|
|
interleukin 27 mediated signaling pathway
|
GO:0070106 |
1 |
0.052
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.051
|
|
|
|
regulation of neuron migration
|
GO:2001222 |
3 |
0.051
|
|
|
|
interleukin 12 production
|
GO:0032615 |
15 |
0.050
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.049
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.049
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.048
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.048
|
Human |
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.047
|
|
|
|
negative regulation of cytosolic calcium ion concentration
|
GO:0051481 |
1 |
0.047
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.047
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.046
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.045
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
67 |
0.044
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
97 |
0.043
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.043
|
|
|
|
regulation of viral genome replication
|
GO:0045069 |
48 |
0.043
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.043
|
Human |
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.043
|
|
|
|
cd8 positive alpha beta t cell proliferation
|
GO:0035740 |
1 |
0.043
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
3 |
0.042
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
91 |
0.042
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.042
|
|
|
|
negative regulation of calcium ion import
|
GO:0090281 |
1 |
0.042
|
|
|
|
rna interference
|
GO:0016246 |
4 |
0.041
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.041
|
Human |
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.041
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.041
|
|
|
|
regulation of macrophage fusion
|
GO:0034239 |
1 |
0.040
|
|
|
|
jak stat cascade
|
GO:0007259 |
46 |
0.040
|
Human |
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
44 |
0.040
|
|
|
|
long term memory
|
GO:0007616 |
2 |
0.039
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.039
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.039
|
Human |
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.039
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
31 |
0.038
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.038
|
|
|
|
positive regulation of immune response
|
GO:0050778 |
159 |
0.038
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.038
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.037
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
49 |
0.037
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
158 |
0.037
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.037
|
|
|
|
regulation of cd8 positive alpha beta t cell activation
|
GO:2001185 |
2 |
0.037
|
|
|
|
regulation of cd8 positive alpha beta t cell proliferation
|
GO:2000564 |
1 |
0.037
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
39 |
0.036
|
Human |
|
|
viral transcription
|
GO:0019083 |
35 |
0.035
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.035
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
45 |
0.035
|
|
|
|
oncostatin m mediated signaling pathway
|
GO:0038165 |
3 |
0.035
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.034
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.034
|
|
|
|
sex determination
|
GO:0007530 |
3 |
0.034
|
|
|
|
hematopoietic stem cell differentiation
|
GO:0060218 |
4 |
0.034
|
|
|
|
interleukin 12 mediated signaling pathway
|
GO:0035722 |
3 |
0.034
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.034
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
3 |
0.034
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.034
|
Human |
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
109 |
0.034
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.033
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.033
|
|
|
|
cellular response to dsrna
|
GO:0071359 |
19 |
0.033
|
|
|
|
regulation of gene expression epigenetic
|
GO:0040029 |
73 |
0.033
|
|
|
|
positive regulation of glial cell proliferation
|
GO:0060252 |
2 |
0.033
|
|
|
|
response to interleukin 13
|
GO:0035962 |
4 |
0.032
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
37 |
0.032
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.032
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.032
|
Human |
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.032
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.032
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.032
|
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
79 |
0.031
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.031
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.031
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
42 |
0.031
|
|
|
|
pattern recognition receptor signaling pathway
|
GO:0002221 |
48 |
0.031
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
54 |
0.031
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.031
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.031
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.031
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
102 |
0.031
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.031
|
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.031
|
Human |
|
|
regulation of membrane potential
|
GO:0042391 |
95 |
0.030
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.030
|
|
|
|
cellular response to growth hormone stimulus
|
GO:0071378 |
10 |
0.030
|
Human |
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.030
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.030
|
|
|
|
production of mirnas involved in gene silencing by mirna
|
GO:0035196 |
12 |
0.030
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.030
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.030
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.029
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.029
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
110 |
0.029
|
|
|
|
growth hormone receptor signaling pathway
|
GO:0060396 |
10 |
0.029
|
Human |
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.028
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
23 |
0.028
|
|
|
|
translation
|
GO:0006412 |
132 |
0.028
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.028
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
28 |
0.028
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.028
|
Human |
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.028
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.027
|
|
|
|
defense response to bacterium
|
GO:0042742 |
63 |
0.027
|
|
|
|
interleukin 13 production
|
GO:0032616 |
7 |
0.027
|
|
|
|
negative regulation of immune response
|
GO:0050777 |
40 |
0.027
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.027
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.027
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.026
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.026
|
Human |
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.026
|
Human |
|
|
regulation of system process
|
GO:0044057 |
101 |
0.026
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.025
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
50 |
0.025
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.025
|
Human |
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.025
|
Human |
|
|
regulation of interleukin 6 mediated signaling pathway
|
GO:0070103 |
3 |
0.025
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.025
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.025
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.025
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.025
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.025
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
22 |
0.025
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.025
|
|
|
|
positive regulation of nucleotide biosynthetic process
|
GO:0030810 |
38 |
0.024
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.024
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.024
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.024
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
77 |
0.024
|
|
|
|
regulation of mononuclear cell proliferation
|
GO:0032944 |
65 |
0.024
|
|
|
|
regulation of cytokine mediated signaling pathway
|
GO:0001959 |
41 |
0.024
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
4 |
0.024
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.024
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.024
|
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.024
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.023
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.023
|
|
|
|
positive regulation of tyrosine phosphorylation of stat3 protein
|
GO:0042517 |
16 |
0.023
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.023
|
|
|
|
interferon gamma production
|
GO:0032609 |
39 |
0.023
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.023
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.023
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
82 |
0.023
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.023
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.023
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.023
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
89 |
0.023
|
|
|
|
ribonucleoprotein complex biogenesis
|
GO:0022613 |
116 |
0.023
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.022
|
|
|
|
negative regulation of leukocyte activation
|
GO:0002695 |
26 |
0.022
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.022
|
|
|
|
ncrna metabolic process
|
GO:0034660 |
108 |
0.022
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.022
|
|
|
|
positive regulation of cytokine biosynthetic process
|
GO:0042108 |
25 |
0.022
|
|
|
|
renal tubule development
|
GO:0061326 |
19 |
0.021
|
Human |
|
|
leukemia inhibitory factor signaling pathway
|
GO:0048861 |
3 |
0.021
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.021
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.021
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.021
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.021
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.021
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.021
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.021
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.021
|
|
|
|
regulation of satellite cell proliferation
|
GO:0014842 |
1 |
0.021
|
|
|
|
cellular response to interleukin 15
|
GO:0071350 |
6 |
0.021
|
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
78 |
0.021
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
68 |
0.021
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.020
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.020
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.020
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.020
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.020
|
|
|
|
interferon gamma mediated signaling pathway
|
GO:0060333 |
7 |
0.020
|
Human |
|
|
glycerolipid metabolic process
|
GO:0046486 |
107 |
0.020
|
|
|
|
single organism nuclear import
|
GO:1902593 |
104 |
0.020
|
Human |
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
117 |
0.020
|
|
|
|
muscle cell cellular homeostasis
|
GO:0046716 |
3 |
0.020
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.020
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.020
|
|
|
|
rna catabolic process
|
GO:0006401 |
71 |
0.020
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.019
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
70 |
0.019
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.019
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
120 |
0.019
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.019
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.019
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.019
|
|
|
|
regulation of dephosphorylation
|
GO:0035303 |
96 |
0.019
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.019
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
18 |
0.019
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.019
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.019
|
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
81 |
0.019
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.018
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.018
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.018
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.018
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.018
|
|
|
|
activation of innate immune response
|
GO:0002218 |
55 |
0.018
|
|
|
|
regulation of intracellular transport of viral material
|
GO:1901252 |
2 |
0.018
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.018
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.018
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.018
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.018
|
|
|
|
regulation of neuron projection regeneration
|
GO:0070570 |
1 |
0.018
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.018
|
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.018
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
56 |
0.018
|
Human |
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.018
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.018
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.018
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
132 |
0.018
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.018
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.017
|
Human |
|
|
positive regulation of defense response to virus by host
|
GO:0002230 |
14 |
0.017
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.017
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
42 |
0.017
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
2 |
0.017
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
38 |
0.017
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
79 |
0.017
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.017
|
Human |
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.017
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.017
|
|
|
|
response to axon injury
|
GO:0048678 |
1 |
0.017
|
|
|
|
positive regulation of notch signaling pathway
|
GO:0045747 |
6 |
0.017
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.017
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
41 |
0.017
|
Human |
|
|
inflammatory response
|
GO:0006954 |
79 |
0.017
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.017
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.016
|
|
|
|
stem cell maintenance
|
GO:0019827 |
19 |
0.016
|
|
|
|
viral gene expression
|
GO:0019080 |
35 |
0.016
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.016
|
|
|
|
negative regulation of binding
|
GO:0051100 |
57 |
0.016
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.016
|
|
|
|
regulation of interleukin 12 biosynthetic process
|
GO:0045075 |
1 |
0.016
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.016
|
|
|
|
activation of protein kinase activity
|
GO:0032147 |
90 |
0.016
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.016
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.016
|
|
|
|
positive regulation of nf kappab transcription factor activity
|
GO:0051092 |
81 |
0.016
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
73 |
0.016
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.016
|
|
|
|
myoblast fusion
|
GO:0007520 |
1 |
0.016
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.015
|
|
|
|
regulation of defense response
|
GO:0031347 |
154 |
0.015
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.015
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
22 |
0.015
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.015
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.015
|
|
|
|
ncrna processing
|
GO:0034470 |
83 |
0.015
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
141 |
0.015
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.015
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.015
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.015
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.015
|
|
|
|
negative regulation of reactive oxygen species biosynthetic process
|
GO:1903427 |
1 |
0.015
|
|
|
|
tumor necrosis factor mediated signaling pathway
|
GO:0033209 |
27 |
0.015
|
Human |
|
|
response to estrogen
|
GO:0043627 |
47 |
0.015
|
Human |
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.014
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
50 |
0.014
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.014
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
45 |
0.014
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.014
|
|
|
|
protein autoubiquitination
|
GO:0051865 |
37 |
0.014
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.014
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.014
|
|
|
|
ribonucleoside biosynthetic process
|
GO:0042455 |
25 |
0.014
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.014
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
2 |
0.014
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
3 |
0.014
|
|
|
|
positive regulation of rig i signaling pathway
|
GO:1900246 |
4 |
0.014
|
|
|
|
regulation of astrocyte differentiation
|
GO:0048710 |
3 |
0.014
|
|
|
|
endosomal transport
|
GO:0016197 |
129 |
0.014
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.014
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
67 |
0.014
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
3 |
0.014
|
|
|
|
positive regulation of gliogenesis
|
GO:0014015 |
4 |
0.014
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
136 |
0.014
|
|
|
|
regulation of axon regeneration
|
GO:0048679 |
1 |
0.014
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.014
|
Human |
|
|
biological adhesion
|
GO:0022610 |
331 |
0.014
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.014
|
Human |
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
4 |
0.013
|
|
|
|
actin filament organization
|
GO:0007015 |
128 |
0.013
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
57 |
0.013
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
33 |
0.013
|
|
|
|
regulation of interleukin 10 production
|
GO:0032653 |
16 |
0.013
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.013
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.013
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.013
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.013
|
|
|
|
negative regulation of protein modification by small protein conjugation or removal
|
GO:1903321 |
41 |
0.013
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.013
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.013
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.013
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.013
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.013
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.013
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.013
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.013
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.013
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.013
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.013
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.013
|
|
|
|
viral life cycle
|
GO:0019058 |
132 |
0.013
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.013
|
|
|
|
regulation of phosphatase activity
|
GO:0010921 |
81 |
0.013
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.013
|
|
|
|
cellular response to interferon alpha
|
GO:0035457 |
4 |
0.013
|
|
|
|
zymogen activation
|
GO:0031638 |
70 |
0.013
|
|
|
|
response to tumor necrosis factor
|
GO:0034612 |
76 |
0.013
|
Human |
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.013
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
64 |
0.013
|
|
|
|
positive regulation of dna metabolic process
|
GO:0051054 |
73 |
0.013
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
56 |
0.013
|
Human |
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.012
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
3 |
0.012
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
46 |
0.012
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
62 |
0.012
|
|
|
|
protein import
|
GO:0017038 |
130 |
0.012
|
Human |
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.012
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.012
|
|
|
|
interleukin 12 biosynthetic process
|
GO:0042090 |
1 |
0.012
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.012
|
|
|
|
regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
GO:2001239 |
20 |
0.012
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.012
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.012
|
Human |
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.012
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.012
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.012
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.012
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.012
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
64 |
0.012
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.012
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.012
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.012
|
|
|
|
visual behavior
|
GO:0007632 |
2 |
0.012
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.012
|
|
|
|
positive regulation of viral process
|
GO:0048524 |
37 |
0.012
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
35 |
0.012
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
57 |
0.012
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
158 |
0.012
|
|
|
|
vacuole organization
|
GO:0007033 |
44 |
0.012
|
|
|
|
positive regulation of protein import into nucleus
|
GO:0042307 |
46 |
0.012
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.012
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.012
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.011
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.011
|
|
